SCA
ELV icon

SAC Capital Advisors’s Elevance Health ELV Stock Holding History

SAC Capital Advisors’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-26,248
Closed -$2.61M – 325
2014
Q1 		$2.61M Buy
26,248
+23,815
+979% +$2.15M 0.01% 707
2013
Q4 		$225K Sell
2,433
-96,055
-98% -$8.53M ﹤0.01% 1574
2013
Q3 		$8.23M Buy
98,488
+96,183
+4,173% +$8.24M 0.04% 430
2013
Q2 		$189K Buy
+2,305
New +$173K ﹤0.01% 1476

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

SAC Capital Advisors's ELV Position: Q2 2014 in Review

SAC Capital Advisors sold out of Elevance Health (ELV) in Q2 2014, closing a stake of 26,248 shares — an estimated $2.61M sold.

SAC Capital Advisors first reported a position in ELV in Q2 2013 and held it in 4 quarters. The position peaked at $8.23M in Q3 2013. 686 funds tracked by Wall St. Rank hold ELV as of Q2 2014.

  • SAC Capital Advisors reported no remaining Elevance Health position as of Q2 2014 after selling out during the quarter.
  • SAC Capital Advisors sold 26,248 Elevance Health shares in Q2 2014, an estimated $2.61M.
  • SAC Capital Advisors first reported a position in Elevance Health in Q2 2013 and held it in 4 quarters.
  • SAC Capital Advisors's Elevance Health position peaked at $8.23M in Q3 2013.
  • 686 funds tracked by Wall St. Rank held Elevance Health as of Q2 2014.

Based on SAC Capital Advisors's 13F filing for Q2 2014.